A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

BMC Medical Research Methodology

Volumn 17, Issue 1, 2017, Pages

  Mistry, Pankaj ^a   Dunn, Janet A ^a   Marshall, Andrea ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adaptive; Adaptive design; Cancer; Clinical trials; Interim analysis; Review

Indexed keywords

HUMAN; METHODOLOGY; ONCOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85024493564     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/s12874-017-0393-6     Document Type: Article

References (18)

1. Chow S-C, Chang M. Adaptive design methods in clinical trials-a review. Orphanet J Rare Dis. 2008;3(11):169-90.
2. Kairalla JA, et al. Adaptive trial designs: a review of barriers and opportunities. Trials. 2012;13(1):145.
3. Food US, Administration D. Adaptive design clinical trials for drugs and biologics. Biotechnol Law Rep. 2010;29(2):173.
4. FDA, Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, U.S.D.o.H.a.H. Services, Editor. 2010.
5. CHMP, CHMP reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design, 2007. 2012.
6. Bauer P, Einfalt J. Application of adaptive designs-a review. Biom J. 2006;48(4):493-506.
7. Stevely A, et al. An Investigation of the Shortcomings of the CONSORT 2010 Statement for the reporting of group sequential randomised controlled trials: a methodological systematic review. PLoS One. 2015;10(11):e0141104.
8. Hatfield I, et al. Adaptive designs undertaken in clinical research: a review of registered clinical trials. Trials. 2016;17(1):1.
9. Bretz F, et al. Adaptive designs for confirmatory clinical trials. Stat Med. 2009;28(8):1181-217.
10. Todd S. A 25-year review of sequential methodology in clinical studies. Stat Med. 2007;26(2):237-52.
11. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549-56.
12. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10(1):1-10.
13. Royston P, Parmar MK, Qian W. Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer. Stat Med. 2003;22(14):2239-56.
14. Medical Research Council Clinical Trials Unit. MAMS Design. Available from: http://www.ctu.mrc.ac.uk/our-research/research-types/methodology1/design/mams-design/. Accessed 23 Feb 2017.
15. CONSORT. Consolidated Standards of Reporting Trials. 2010. Available from: http://www.consort-statement.org/. Accessed 10 Apr 2017.
16. Hopewell S, et al. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371(9609):281-3.
17. Hopewell S, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5(1):e20.
18. Ioannidis JP, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141(10):781-8.